Page last updated: 2024-08-22

megestrol and etoposide

megestrol has been researched along with etoposide in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bauer, M; Bennett, JM; Creech, R; Hahn, RG; Wampler, G; Wolter, J1
Bowman, CA; Fetherstonhaugh, EM; Gelmon, K; Karsai, H; Knowling, MA; Mclaughlin, MJ; Murray, N; Osoba, D; Page, R; Shah, A1
Baker, TR; Cornelison, TL; Driscoll, DL; Piver, MS1
Ghosh, C; Jett, JR; Jung, SH; Kugler, JW; Kuross, SA; Loprinzi, CL; Mailliard, JA; Maksymiuk, AW; Owen, D; Rowland, KM; Schaefer, PL; Shaw, EG; Tschetter, LK; Washburn, JH; Webb, TA1
Bonner, JA; Klee, GG; Krook, JE; Kugler, JW; Mailliard, JA; Maksymiuk, AW; Marks, RS; Perez, EA; Rowland, KM; Shaw, EG; Sloan, JA; Wiesenfeld, M1

Reviews

1 review(s) available for megestrol and etoposide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

5 trial(s) available for megestrol and etoposide

ArticleYear
Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer.
    Cancer treatment reports, 1979, Volume: 63, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Drug Evaluation; Etoposide; Humans; Kidney Neoplasms; Megestrol; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Sugar Alcohols

1979
Phase II trial of megestrol in the supportive care of patients receiving dose-intensive chemotherapy.
    Oncology (Williston Park, N.Y.), 1994, Volume: 8, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Etoposide; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Megestrol; Middle Aged; Mitomycins; Vincristine; Weight Loss

1994
Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma.
    Gynecologic oncology, 1995, Volume: 59, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Melphalan; Middle Aged; Prospective Studies; Survival Rate

1995
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:1

    Topics: Anorexia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cachexia; Carcinoma, Small Cell; Cisplatin; Double-Blind Method; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Pain Measurement; Quality of Life; Survival Analysis; Survival Rate; Thromboembolism

1996
Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Megestrol; Middle Aged; Neoplasm Staging; Phosphopyruvate Hydratase; Survival Rate; Time Factors

2000